Risk factors associated with human papillomavirus infection status in a Korean cohort

Epidemiology and Infection

Volumn 142, Issue 8, 2014, Pages 1579-1589

  Lee, H ^a   Lee, D H ^a   Song, Y M ^b   Lee, K ^c   Sung, J ^a   Ko, G ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

HPV infection; oral contraceptive; risk factor; sexual behaviour; twins

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTRACEPTIVE BEHAVIOR; DISEASE ASSOCIATION; DNA SEQUENCE; EDUCATIONAL STATUS; EXTRAMARITAL SEX; FEMALE; GENOTYPE; GROUPS BY AGE; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; INFECTION RATE; INFECTION RISK; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MEDICAL HISTORY; NUCLEOTIDE SEQUENCE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PHYLOGENY; PREVALENCE; REPRODUCTIVE BEHAVIOR; RISK ASSESSMENT; RISK FACTOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SMOKING; SOUTH KOREA; TWINS; VAGINAL LAVAGE; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORAL CONTRACEPTIVE USE; REVIEW; SEXUAL BEHAVIOR; VAGINA SMEAR;

ADULT; AGED; COHORT STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPUBLIC OF KOREA; RISK FACTORS; SEXUAL BEHAVIOR; TWINS; VAGINA; VAGINAL DOUCHING;

EID: 84902436335     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813002549     Document Type: Article

References (49)

1. Ferlay J, et al. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 In. Lyon, France: International Agency for Research on Cancer, 2010.
2. Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology 1999; 189: 12-19.
3. Initiative for vaccine research (http://www.who.int/vaccine-research/ diseases/viral-cancers/en/index3.html). Accessed 5 December 2012.
4. Schiffman M, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Research 2010; 70: 3159-3169.
5. Munoz N, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine 2003; 3 48: 518-527.
6. Villa LL. HPV prophylactic vaccination: the first years and what to expect from now. Cancer Letters 2011; 305: 106-112.
7. Clifford GM, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-998.
8. de Sanjose S, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infectious Diseases 2007; 7: 453-459.
9. Kim YT. Current status of cervical cancer and HPV infection in Korea. Journal of Gynecologic Oncology 2009; 20: 1-7.
10. Shin HR, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. Journal of infectious diseases 2004; 190: 468-476.
11. Joo WD, et al. Prevalence of human papillomavirus infection in Korean women: risks of abnormal pap smear and cervical neoplasia. Korean Journal of Gynecologic Oncology and Colposcopy 2004; 15: 309-316.
12. Shin HR, et al. Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data. International Journal of Cancer 2008; 122: 393-397.
13. Koushik A, Platt RW, Franco EL. p53 codon 72 polymorphism and cervicalneoplasia: a meta-analysis review. Cancer Epidemiology, Biomarkers & Prevention 2004; 13: 11-22.
14. de Araujo Souza PS, Villa LL. Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil. Mutation Research 2003; 544: 375-383.
15. Chan PK, et al. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese. Journal of Medical Virology 2007; 79: 970-976.
16. Kim CJ, et al. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea. International Journal of Gynecological Cancer 2010; 20: 1067-1073.
17. Louie KS, et al. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. British Journal of Cancer 2009; 100: 1191-1197.
18. Moreno V, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002; 359: 1085-1092.
19. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Research 2002; 89: 191-199.
20. La Ruche G, et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. International Journal of Cancer 1998; 76: 480-486.
21. Siegel EM, et al. Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecologic Oncology 2010; 118: 289-294.
22. Cust AE. Physical activity and gynecologic cancer prevention. Recent Results in Cancer Research 2011; 186: 159-185.
23. King CC, et al. Bacterial vaginosis and the natural history of human papillomavirus. Infectious Diseases in Obstetrics and Gynecology 2011; 2011: 319-460.
24. Gillet E, et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infectious Diseases 2011; 11: 10.
25. Veldhuijzen NJ, et al. Factors affecting transmission of mucosal human papillomavirus. Lancet Infectious Diseases 2010; 10: 862-874.
26. Ye J, et al. Risk factors triage on high-risk human papil-lomavirus testing screening. International Journal of Gynecological Cancer 2010; 20: 1374-1380.
27. Vinodhini K, et al. Prevalence and risk factors of HPV infection among women from various provinces of the world. Archives of Gynecology and Obstetrics 2012; 285: 771-777.
28. Liu SS, et al. Prevalence and risk factors of human papillomavirus (HPV) infection in southern Chinese women- A population-based study. PLoS One 2011; 6: e19244.
29. Sung J, et al. Healthy Twin: a twin-family study of Korea-protocols and current status. Twin Research and Human Genetics 2006; 9: 844-848.
30. Gravitt PE, et al. Improved amplification of genital human papillomaviruses. Journal of Clinical Microbiology 2000; 38: 357-361.
31. Jacobs MV, et al. Group-specific differentiation between high-and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. Journal of Clinical Microbiology 1995; 33: 901-905.
32. Tamura K, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular Biology and Evolution 2011; 28: 2731-2739.
33. Guzalinuer A, et al. Association between HPV infection and HLA-DQB1 alleles polymorphism in the cervical carcinogenesis in Uyghur women in southern Xinjiang. Chinese Journal of Oncology 2010; 32: 492-496.
34. Vink JM, et al. Cervix smear abnormalities: linking pathology data in femaletwins, their mothers and sisters. European Journal of Human Genetics 2011; 19: 108-111.
35. Munoz N, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24 (Suppl. 3): S3/1-10.
36. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections 1999; 75: 3-17.
37. Kim MA, et al. Prevalence and seroprevalence of high-risk human papillomavirus infection. Obstetrics and Gynecology 2010; 116: 932-940.
38. Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006; 20: 2337-2344.
39. Burchell AN, et al. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24 (Suppl. 3): S3/52-61.
40. Ghanem KG, et al. The association of current hormonal contraceptive use with type-specific HPV detection. Sexually Transmitted Infections 2011; 87: 385-388.
41. Lee JE, et al. Association of the vaginal microbiota with human papillomavirus infection in a korean twin cohort. PLoS One 2013; 8: e63514.
42. McIntyre-Seltman K, et al. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among onco-genic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiology, Biomarkers & Prevention 2005; 14: 1165-1170.
43. Trimble CL, et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstetrics and Gynecology 2005; 105: 174-181.
44. Martino JL, Vermund SH. Vaginal douching: evidence for risks or benefits to women's health. Epidemiologic Reviews 2002; 24: 109-124.
45. Beck-Sague CM, et al. Detection of Chlamydia trachomatis cervical infection by urine tests among adolescents clinics. Journal of Adolescent Health 1998; 22: 197-204.
46. Stergachis A, et al. Selective screening for Chlamydia trachomatis infection in a primary care population of women. American Journal of Epidemiology 1993; 138: 143-153.
47. Tarkowski TA, et al. Epidemiology of human papillo-mavirus infection and abnormal cytologic test results in an urban adolescent population. Journal of Infectious Diseases 2004; 189: 46-50.
48. Srinivasan S, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PloS One 2010; 5: e10197.
49. Low A, et al. Cervical infection with human papilloma-virus (HPV) 6 or 11 in high-risk women in Burkina Faso. Sexually Transmitted Infections 2010; 86: 342-344.